Methods of using (+)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione

  • US 9,724,330 B2
  • Filed: 02/05/2016
  • Issued: 08/08/2017
  • Est. Priority Date: 03/20/2002
  • Status: Active Grant
First Claim
Patent Images

1. A method of treating an autoimmune disease, the method comprising administering to a patient having the autoimmune disease a therapeutically effective amount of stereomerically pure (+)-2-[1-(3-ethoxy-4-methoxyphenyl) -2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×